Clinical Characteristics of Patients with Nontuberculous Mycobacterium Pulmonary Disease in Fuyang, China: A Retrospective Study

Overview

Journal Infect Drug Resist

Publisher Dove Medical Press

Date 2024 Sep 19

PMID 39296777

Authors

Xiaowu Wang

Tuantuan Li

Yan Liu

Yilang Zhu

Lichang Chen

Yong Gao

Affiliations

Soon will be listed here.

Abstract

Objective: We retrospectively review consecutive patients with nontuberculous mycobacterium (NTM) pulmonary disease reported from a designated hospital for infectious diseases in the Fuyang district of China to determine the clinical characteristics of these patients.

Methods: This research enrolled 234 patients with NTM pulmonary disease between January 2018 and May 2023 in the Fuyang district of China. Data were collected from the electronic medical records. The NTM strain composition and clinical characteristics of NTM pulmonary disease were retrospectively analyzed.

Results: 73 (31.20%) patients had previous tuberculosis (TB) or TB exposure history and bronchiectasis. Mixed NTM infection accounted for 12.39%. strain was detected in 132 patients (49.62%). Women were found to be more affected by infection, and men by infection. (34.21%) and (33.33%) strains were most common in people with previous TB or TB exposure history. Among respiratory tract-related diseases, patients with bronchiectasis had the highest isolation rate of (55.36%). Women were susceptible to bronchiectasis ( <0.01). The median of mononuclear-to-lymphocyte ratio (MLR) was higher in men than in women (P < 0.01). The serum albumin (ALB) level was lower in patients with TB or TB exposure history than in those without TB history ( = 0.034). The prognostic nutritional index (PNI) was lower in patients with TB or TB exposure history than in those without tuberculosis history ( = 0.021). Patients with NTM lung disease were poorly treated.

Conclusion: Clinical symptoms of the disease were not species-specific. and strains were predominant in the Fuyang district of China. Previous TB or TB exposure history immensely enhanced the risk of NTM disease.

References

Philley J, Griffith D . Medical Management of Pulmonary Nontuberculous Mycobacterial Disease. Thorac Surg Clin. 2018; 29(1):65-76. DOI: 10.1016/j.thorsurg.2018.09.001. View

Maiz L, Giron R, Olveira C, Vendrell M, Nieto R, Martinez-Garcia M . Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study. BMC Infect Dis. 2016; 16(1):437. PMC: 4994165. DOI: 10.1186/s12879-016-1774-x. View

Pfaeffle H, Alameer R, Marshall M, Houpt E, Albon D, Heysell S . Clofazimine for treatment of multidrug-resistant non-tuberculous mycobacteria. Pulm Pharmacol Ther. 2021; 70:102058. DOI: 10.1016/j.pupt.2021.102058. View

Lopes M, Batista M, Garcia T, Alves H, Boaventura L, Pontes C . Non-tuberculous mycobacteria: clinical and laboratory characterisation (2009 and 2019). Epidemiol Infect. 2022; 151:e8. PMC: 9990399. DOI: 10.1017/S0950268822000899. View

Daley C, Iaccarino J, Lange C, Cambau E, Wallace Jr R, Andrejak C . Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J. 2020; 56(1). PMC: 8375621. DOI: 10.1183/13993003.00535-2020. View

Zhang Z, Pang Y, Wang Y, Cohen C, Zhao Y, Liu C . Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China. Int J Antimicrob Agents. 2015; 45(5):491-5. DOI: 10.1016/j.ijantimicag.2015.01.012. View

Wang J, Chen Z, Xu Y, Qiu W, Chen S, Pei H . Screening and Drug Resistance Analysis of Non-Tuberculous Mycobacteria in Patients with Suspected Pulmonary Tuberculosis on the Hainan Island, China. Infect Drug Resist. 2023; 16:463-476. PMC: 9884444. DOI: 10.2147/IDR.S396050. View

Hashemi Shahraki A, Heidarieh P, Bostanabad S, Khosravi A, Hashemzadeh M, Khandan S . "Multidrug-resistant tuberculosis" may be nontuberculous mycobacteria. Eur J Intern Med. 2015; 26(4):279-84. PMC: 4414892. DOI: 10.1016/j.ejim.2015.03.001. View

Schildknecht K, Winthrop K, Prevots D, Blakney R, Henkle E . Nontuberculous mycobacterial pulmonary disease incidence among elderly patients with bronchiectasis. Eur Respir J. 2022; 59(6). DOI: 10.1183/13993003.00018-2022. View

10.

Ming Li Y, Tong X, Xu H, Ju Y, Cai M, Wang C . Prevalence and Antimicrobial Susceptibility of Mycobacterium abscessus in a General Hospital, China. Biomed Environ Sci. 2016; 29(2):85-90. DOI: 10.3967/bes2016.009. View

11.

Karamat A, Ambreen A, Ishtiaq A, Tahseen S, Rahman M, Mustafa T . Isolation of non-tuberculous mycobacteria among tuberculosis patients, a study from a tertiary care hospital in Lahore, Pakistan. BMC Infect Dis. 2021; 21(1):381. PMC: 8070300. DOI: 10.1186/s12879-021-06086-8. View

12.

Huang T, Lee C, Tu H, Shin-Jung Lee S . Rapid identification of mycobacteria from positive MGIT broths of primary cultures by MALDI-TOF mass spectrometry. PLoS One. 2018; 13(2):e0192291. PMC: 5796708. DOI: 10.1371/journal.pone.0192291. View

13.

Meghji J, Lesosky M, Joekes E, Banda P, Rylance J, Gordon S . Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study. Thorax. 2020; 75(3):269-278. PMC: 7063395. DOI: 10.1136/thoraxjnl-2019-213808. View

14.

Hu C, Huang L, Cai M, Wang W, Shi X, Chen W . Characterization of non-tuberculous mycobacterial pulmonary disease in Nanjing district of China. BMC Infect Dis. 2019; 19(1):764. PMC: 6719376. DOI: 10.1186/s12879-019-4412-6. View

15.

Liu H, Zhang T, Wang Y, Fan H, Huang X, Jiao Y . Clinical features of patients presenting with fever of unknown origin caused by non-tuberculous mycobacterium infection. J Infect Dev Ctries. 2023; 17(7):1014-1021. DOI: 10.3855/jidc.17610. View

16.

Kartalija M, Ovrutsky A, Bryan C, Pott G, Fantuzzi G, Thomas J . Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes. Am J Respir Crit Care Med. 2012; 187(2):197-205. PMC: 5446199. DOI: 10.1164/rccm.201206-1035OC. View

17.

Almutairi T, Almohaya A, Alqahtani A, Alkinani O, Alasmari F, Binkhamis K . Clinical characteristics and imaging features of patients with nontuberculous mycobacteria in a tertiary care center. J Clin Tuberc Other Mycobact Dis. 2022; 26:100294. PMC: 8739879. DOI: 10.1016/j.jctube.2021.100294. View

18.

Adjemian J, Frankland T, Daida Y, Honda J, Olivier K, Zelazny A . Epidemiology of Nontuberculous Mycobacterial Lung Disease and Tuberculosis, Hawaii, USA. Emerg Infect Dis. 2017; 23(3):439-447. PMC: 5382761. DOI: 10.3201/eid2303.161827. View

19.

Kim B, Kang N, Kim S, Kim D, Kim H, Kwon O . The lung microbiota in nontuberculous mycobacterial pulmonary disease. PLoS One. 2023; 18(5):e0285143. PMC: 10218745. DOI: 10.1371/journal.pone.0285143. View

20.

Cowman S, van Ingen J, Griffith D, Loebinger M . Non-tuberculous mycobacterial pulmonary disease. Eur Respir J. 2019; 54(1). DOI: 10.1183/13993003.00250-2019. View